Tenofovir Disoproxil Fumarate Drug Combination Emtricitabine FDA Link

A pharmaceutical preparation of emtricitabine and tenofovir that is used as an ANTI-HIV AGENT in the treatment and prevention of HIV INFECTIONS.

Also Known As:

Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Emtricitabine Tenofovir Disoproxil Fumarate Drug Combination; Emtricitabine-Tenofovir Disoproxil Fumarate Drug Combination; Truvada

Organic Chemicals: 133
- Organophosphorus Compounds: 300
  - Organophosphonates: 424
    - Tenofovir: 2723
      - Tenofovir Disoproxil Fumarate Drug Combination Emtricitabine: 49
Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyrimidines: 510
    - Pyrimidine Nucleosides: 50
      - Cytidine: 535
        Deoxycytidine: 307
        Emtricitabine: 628
        Tenofovir Disoproxil Fumarate Drug Combination Emtricitabine: 49
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Purines: 651
      - Adenine: 2120
        Tenofovir: 2723
        Tenofovir Disoproxil Fumarate Drug Combination Emtricitabine: 49
Nucleic Acids, Nucleotides, and Nucleosides: 1
- Nucleosides: 6847
  - Pyrimidine Nucleosides: 50
    - Cytidine: 535
      - Deoxycytidine: 307
        Emtricitabine: 628
        Tenofovir Disoproxil Fumarate Drug Combination Emtricitabine: 49
  - Deoxyribonucleosides: 34
    - Deoxycytidine: 307
      - Emtricitabine: 628
        Tenofovir Disoproxil Fumarate Drug Combination Emtricitabine: 49
Pharmaceutical Preparations
- Drug Combinations: 5337
  - Tenofovir Disoproxil Fumarate Drug Combination Emtricitabine: 49

José Vicente Fernández Selected Research

José Vicente Fernández Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure